The Cancer Immunoediting Theory
July 7, 2026Core Framework & Diagram Why Does Cancer Relapse?
July 7, 2026
It was 'cured' — then five years later it came back, and it's harder to treat than before
By the Editors 1-min read
Breast cancer surgery plus chemotherapy, 'clinical remission' — then bone metastasis confirmed three years later. Colorectal cancer surgically resected clean, five years of 'disease-free survival' follow-up — but the seventh year, metastatic lesions appear in the liver. Cancer relapse is the heaviest shadow hanging over every 'clinically remissed' patient.
'Remission' doesn't equal 'cure' — outside the range visible to current imaging and blood tests, a small number of cancer cells may still be surviving somewhere, quietly waiting for opportunity. These invisible residual cancer cells are called 'Minimal Residual Disease' (MRD). Cancer relapse isn't bad luck — it's MRD breaking through the equilibrium line again under new conditions after weathering immune pressure.
KEY TAKEAWAYS
01
Cancer relapse comes from three types of residual cells: treatment-resistant subclones (rapid relapse after treatment), cancer stem cells (CSCs, activating after years of dormancy causing late relapse), and immune escape subclones (resistance relapse after immunotherapy). Relapsed tumors usually simultaneously possess multiple relapse mechanisms, more drug-resistant than at initial diagnosis.
02
Minimal residual disease (MRD) is the biological root of all relapse: 'clinical remission' doesn't equal 'tumor eliminated,' only falling below traditional detection method thresholds. ctDNA liquid biopsy can detect MRD approximately six months before clinical imaging relapse, providing early intervention windows.
03
Cancer stem cell (CSC) dormancy mechanism explains 'late relapse' (over 10 years): chemotherapy eliminated ninety-nine percent of cancer cells, but CSCs hibernate in distant tissue, rebuilding the tumor after being awakened by immunosenescence or hormonal changes. Extending adjuvant endocrine therapy from five to ten years targets this mechanism.
04
Psychological stress (catecholamines suppressing NK cells) and sleep deprivation (damaging NK cell function) are immune 'relapse triggers' with direct biological mechanism support. Regular exercise can reduce breast cancer relapse risk by twenty to forty percent — a well-evidenced behavioral intervention strategy.
05
Adjuvant immune checkpoint inhibitor treatment (for melanoma, some lung cancer) and MRD-guided dynamic treatment adjustment are the most evidence-supported medical strategies for reducing relapse risk.
Art 74
Why Does Cancer Metastasize?
→
Art 75
How Does Inflammation Promote Cancer?
→
